Benchmark Research has ‘been there, done that’ when it comes to any nuance pertaining to clinical trials. Having developed organically since 1997, Benchmark currently has over 150 employees and eight executives on their leadership team. Be it for a pharmaceutical company or a CRO, they do this at no cost via an honest working relationship.īetter Trial Integrations through Experience Concurrently, the company participates in clients’ bid defenses and works with them to analyze their protocols. With more strategic collaborations with Clinical Research Organizations (CROs) and more pharmaceutical companies than almost any other sites, Benchmark Research shares a very close relationship with them to deliver the best results. ![]() Benchmark Research, in this regard, is launching an initiative to address diversity and inclusion in clinical research as well. ![]() Since the outbreak, it has been imperative for clinical researchers to have the proper number of distribution subjects across multiple ethnicities participating in trials. Not only is Benchmark Research geographically diverse, but the company also has key programs for racial diversity across clinical trials. Our teams of motivated and focused investigators offer clinical trials expertise in a wide range of therapeutic areas, embracing clinical research opportunities that new therapies bring to the marketplace and patients To address this, Benchmark Research has been focusing on both a high volume of study patients for clients and delivering consistent quality data on them. As a result, many studies ran behind, costing pharmaceutical companies millions of dollars. Pharma companies have always struggled with recruiting qualified volunteers to participate in their studies, especially in the wake of the pandemic. ![]() Worth, San Angelo, San Antonio, North Shore, New Orleans, Sacramento, and Los Angeles. Today, the company has eight Clinical Sites around the U.S.-Austin, Ft. We nurture a family culture, rather than a corporate one,” says Mark Lacy, CEO, Benchmark Research. As such, we have a lot of loyalty built up with Benchmark Research. Most of our workforce has been together for over 15 years. We embrace clinical research opportunities that new therapies bring to the marketplace and patients. “Our teams of motivated and focused investigators offer clinical trials expertise in a wide range of therapeutic areas. Additionally, the company is running another 92+ vaccine device, treatment, and hospital coronavirus studies, which puts them in the unique position of doing more coronavirus work in the United States than most any other company. Benchmark Research was founded in 1997 by Mark Lacy, CEO, and Scott Barrett, President, who have developed a track record of safety and expertise, having conducted more than 1,000 trials with 40,000+ participants.īenchmark has met and mostly exceeded enrollment goals in all seven fast tracked trials. To this end, Benchmark Research-an industry leader in the clinical trials space, specializing in conducting investigational vaccine trials-is one of the companies chosen to conduct these crucial studies sponsored by the federal government and the RDA, for the roll-out of COVID-19 vaccines. COVID-19 vaccination program.īehind all the decision-making, numbers, statistics, and legislation are the people who worked night and day tirelessly to make it all happen. Because of limited initial vaccine supply, the Advisory Committee on Immunization Practices (ACIP) prioritized vaccination of health care personnel and residents and staff members of long-term care facilities (LTCF) during the first phase of the U.S. According to the Centre for Disease Control (CDC), two COVID-19 vaccines (Pfizer-BioNTech and Moderna) were authorized for emergency use in the United States in December of 2020. ![]() Top clinical research firms worldwide continue to be busy conducting investigational studies to develop new vaccines and medicines. It has been quite the journey over the last 12 months, and much has been achieved in record time. Mark Lacy, CEO The speed and urgency in which vaccines were rolled out for the recent pandemic was unprecedented.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |